Abstract
Purpose
Hematuria is one of the most common laboratory findings in nephrology practice. To date, there is no enough data regarding the clinical and histopathologic characteristics of primary glomerular disease (PGD) patients with hematuria in our country.
Methods
Data were obtained from national multicenter (47 centers) data entered into the Turkish Society of Nephrology Glomerular Diseases (TSN-GOLD) database between May 2009 and June 2019. The data of all PGD patients over the age of 16 years who were diagnosed with renal biopsy and had hematuria data were included in the study. Demographic characteristics, laboratory and biopsy findings were also recorded.
Results
Data of 3394 PGD patients were included in the study. While 1699 (50.1%) patients had hematuria, 1695 (49.9%) patients did not have hematuria. Patients with hematuria had statistically higher systolic blood pressure, serum blood urea nitrogen, creatinine, albumin, levels and urine pyuria. However, these patients had statistically lower age, body mass index, presence of hypertension and diabetes, eGFR, 24-h proteinuria, serum total, HDL and LDL cholesterol, and C3 levels when compared with patients without hematuria. Hematuria was present 609 of 1733 patients (35.8%) among the patients presenting with nephrotic syndrome, while it was presented in 1090 of 1661 (64.2%) patients in non-nephrotics (p < 0.001).
Conclusion
This is the first multicenter national report regarding the demographic and histopathologic data of PGD patients with or without hematuria. Hematuria, a feature of nephritic syndrome, was found at a higher than expected in the PGDs presenting with nephrotic syndrome in our national database.
Similar content being viewed by others
Data availability
We created a database for primary glomerular diseases with the name of ‘Turkish Society of Nephrology Glomerular Diseases Working Group (TSN-GOLD) in 04.04.2008. We published the first results of our study in 2012 in Internal Urology and Nephrology [10]. This study is a retrospective study on the epidemiologic data of patients who underwent native kidney biopsy between 2009 and 2019 and diagnosed as ‘primary glomerular disease’ extracted from the ‘Primary Glomerulonephritis Registry of Turkish Society of Nephrology’ database. https://pgh.tsn.org.tr/login.php.
References
Bolenz C, Schroppel B, Eisenhardt A, Schmitz-Drager BJ, Grimm MO (2018) The investigation of hematuria. Dtsch Arztebl Int 115(48):801–807
Topham PS, Harper SJ, Furness PN, Harris KP, Walls J, Feehally J (1994) Glomerular disease as a cause of isolated microscopic haematuria. Q J Med 87(6):329–335
Yuste C, Rivera F, Moreno JA, Lopez-Gomez JM (2016) Haematuria on the Spanish registry of glomerulonephritis. Sci Rep 6:19732
Cohen RA, Brown RS (2003) Clinical practice. Microscopic hematuria N Engl J Med 348(23):2330–2338
Ong LM, Punithavathi N, Thurairatnam D, Zainal H, Beh ML, Morad Z et al (2013) Prevalence and risk factors for proteinuria: the National Kidney Foundation of Malaysia Lifecheck Health Screening programme. Nephrology (Carlton) 18(8):569–575
Moreno JA, Sevillano A, Gutierrez E, Guerrero-Hue M, Vazquez-Carballo C, Yuste C et al (2019) Glomerular hematuria: cause or consequence of renal inflammation? Int J Mol Sci 20(9):2205
Gutierrez E, Gonzalez E, Hernandez E, Morales E, Martinez MA, Usera G et al (2007) Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy. Clin J Am Soc Nephrol 2(1):51–57
Ding JY, Ibanez D, Gladman DD, Urowitz MB (2015) Isolated hematuria and sterile pyuria may indicate systemic lupus erythematosus activity. J Rheumatol 42(3):437–440
Rhee RL, Davis JC, Ding L, Fervenza FC, Hoffman GS, Kallenberg CGM et al (2018) The utility of urinalysis in determining the risk of renal relapse in ANCA-associated vasculitis. Clin J Am Soc Nephrol 13(2):251–257
Ozturk S, Sumnu A, Seyahi N, Gullulu M, Sipahioglu M, Artan S et al (2014) Demographic and clinical characteristics of primary glomerular diseases in Turkey. Int Urol Nephrol 46(12):2347–2355
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612
Couser WG (1988) Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 11(6):449–464
Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ et al (2003) Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol 14(7 Suppl 2):S131–S138
Moreno JA, Martin-Cleary C, Gutierrez E, Rubio-Navarro A, Ortiz A, Praga M et al (2012) Haematuria: the forgotten CKD factor? Nephrol Dial Transplant 27(1):28–34
Auwardt R, Savige J, Wilson D (1999) A comparison of the clinical and laboratory features of thin basement membrane disease (TBMD) and IgA glomerulonephritis (IgA GN). Clin Nephrol 52(1):1–4
Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368(25):2402–2414
Greenhall GH, Salama AD (2015) What is new in the management of rapidly progressive glomerulonephritis? Clin Kidney J 8(2):143–150
Abrass CK (1997) Clinical spectrum and complications of the nephrotic syndrome. J Investig Med 45(4):143–153
Lionaki S, Liapis G, Boletis JN (2019) Pathogenesis and Management of acute kidney injury in patients with nephrotic syndrome due to primary glomerulopathies. Medicina (Kaunas) 55(7):365
Maillard N, Wyatt RJ, Julian BA, Kiryluk K, Gharavi A, Fremeaux-Bacchi V et al (2015) Current understanding of the role of complement in IgA nephropathy. J Am Soc Nephrol 26(7):1503–1512
Zhu L, Zhai YL, Wang FM, Hou P, Lv JC, Xu DM et al (2015) Variants in complement factor H and complement factor H-related protein genes, CFHR3 and CFHR1, affect complement activation in IgA nephropathy. J Am Soc Nephrol 26(5):1195–1204
Rodrigues JC, Haas M, Reich HN (2017) IgA nephropathy. Clin J Am Soc Nephrol 12(4):677–686
Rychlik I, Jancova E, Tesar V, Kolsky A, Lacha J, Stejskal J et al (2004) The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994–2000. Nephrol Dial Transplant 19(12):3040–3049
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
Concept—K.T., A.S., and S.O.; design—K.T., A.S., and S.O.; supervision—A.T. and S.O.; resources—A.S., E.C., N.E., and K.T.; data collection and/or processing: all the authors from 47 centers; analysis and/or ınterpretation—K.T., A.S., and S.O.; literature search—A.S., E.C., N.E., and K.T.; writing manuscript—K.T., A.S., and S.O. All the authors read and approved the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethics approval
The Ethics Committee of Istanbul University, Istanbul Medical Faculty approved the study.
Consent for participation
Due to retrospective nature of the study, informed consent was not received.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sumnu, A., Turkmen, K., Cebeci, E. et al. Characteristics of primary glomerular diseases patients with hematuria in Turkey: the data from TSN-GOLD Working Group. Int Urol Nephrol 53, 945–954 (2021). https://doi.org/10.1007/s11255-020-02690-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-020-02690-w